Market News & Trends
Rubius Therapeutics Announces First Patient Dosed in Phase 1b Trial of RTX-134
Rubius Therapeutics, Inc. recently announced that the first patient has been dosed in its Phase 1b trial of RTX-134, an allogeneic, off-the-shelf cellular therapy for…
Vetter Aligns its Development Service Laboratory Portfolio
Vetter, a global operating Contract Development and Manufacturing Organization (CDMO) has brought together its development laboratories in one Ravensburg site end of last year. Designed…
Avacta’s Proprietary TMAC Cancer Therapy Platform Demonstrates Successful Proof-of-Concept
Avacta Group plc recently announced it has demonstrated initial proof-of-concept for its proprietary new class of drug conjugate, TMAC, in a preclinical animal model of…
Cabaletta Bio Receives Orphan Drug Designation for DSG3-CAART
Cabaletta Bio, Inc. recently announced that the US FDA has granted Orphan Drug Designation for the company’s lead product candidate, DSG3-CAART, for the treatment of…
Akcea & Ionis Report Positive Topline Phase 2 Study Results
Akcea Therapeutics, Inc. and Ionis Pharmaceuticals, Inc. recently announced positive topline results from the Phase 2 study of AKCEA-ANGPTL3-LRx in patients with hypertriglyceridemia, type 2…
Hovione Technology Announces Key Patent Grants for its Large-Dose DPI
Hovione Technology recently announced the notice of patent grants in key territories of the world for one of its Large-Dose dry powder inhaler (DPI) platforms,…
Drug Developers Are Making Strides in Streamlining Patient Recruitment & Retention for Clinical Trials
Efforts by drug developers during the past decade to improve recruitment and retention of patients for clinical trials appear to be paying off, as enrollment…
Theralase Granted US Patent for Multiwavelength Photodynamic Therapy
Theralase Technologies Inc. recently announced it has been granted a US Patent for Multiwavelength PhotoDynamic Therapy (PDT) technology. The US patent, titled Apparatus and Method…
GeoVax & BravoVax to Collaborate on Development of Coronavirus Vaccine
GeoVax Labs, Inc. and BravoVax recently announced the signing of a Letter of Intent to jointly develop a vaccine against the new coronavirus (known as…
Krystal Biotech Breaks Ground On Second Commercial Gene Therapy Manufacturing Facility
Krystal Biotech, Inc. recently announced the ground breaking of the second commercial gene therapy facility in Findlay Township, PA. The Findlay-based Current Good Manufacturing Practice…